Effective July 27, 2023: Texas Medicaid Preferred Drug List Updates
Date: 06/22/23
Texas Health and Human Services (HHS) will perform the semi-annual update of the Texas Medicaid preferred drug list (PDL) on July 27, 2023. HHS will make the PDL changes based on recommendations made at the January and April 2023 Texas Drug Utilization Review Board meetings. Superior HealthPlan follows the Texas Medicaid Vendor Drug Formulary and the PDL.
The tables below summarize some of the anticipated noteworthy changes.
Please note: The tables are not the complete list of changes. Please reference the Texas Medicaid PDL for a complete list of recommended medications, or visit the DUR Board webpage on the Texas Vendor Drug website for a list of all decisions.
The first table below includes the January PDL update changes from the January PDL decisions:
PDL Class | Drug | Current PDL Status | Recommended Status |
|---|---|---|---|
Antimigraine Agents, other | Ubrelvy (oral) | Non-preferred | Preferred |
Bladder Relaxant Preparations | Myrbetriq (oral) | Non-preferred | Preferred |
Bladder Relaxant Preparations | Myrbetriq granules (oral) | Non-preferred | Preferred |
Glucagon Agents | Gvoke pen (subcutaneous) | Non-preferred | Preferred |
Glucagon Agents | Gvoke syringe (subcutaneous) | Preferred | Non-preferred |
Intranasal Rhinitis Agents | Ryaltris (nasal) | Not reviewed | Non-preferred |
Movement Disorders | Tetrabenazine (oral) | Preferred | Non-preferred |
Movement Disorders | Xenazine (oral) | Non-preferred | Preferred |
Pulmonary Arterial Hypertension Agents, oral and inhaled | Tadliq suspension (oral) | Not reviewed | Non-preferred |
Stimulants and Related Agents | Dyanavel XR tablet (oral) | Not reviewed | Non-preferred |
Stimulants and Related Agents | Quillichew ER (oral) | Preferred | Non-preferred |
Stimulants and Related Agents | Xelstrym (transdermal) | Not reviewed | Non-preferred |
Single Drug Reviews |
|
|
|
Anticonvulsants | Zonisade (oral) | Not reviewed | Preferred |
Anticonvulsants | Ztalmy (oral) | Not reviewed | Preferred |
Antidepressants, other | Auvelity (oral) | Not reviewed | Non-preferred |
Benign Prostatic Hyperplasia Treatments | Entadfi (oral) | Not reviewed | Non-preferred |
Colony Stimulating Factor | Fylnetra (subcutaneous) | Not reviewed | Non-preferred |
Cytokine and Cam Antagonists | Skyrizi on-body (subcutaneous) | Not reviewed | Non-preferred |
Cytokine and Cam Antagonists | Sotyktu (oral) | Not reviewed | Non-preferred |
Multiple Sclerosis Agents | Tascenso ODT (oral) | Not reviewed | Preferred |
Urea Cycle Disorders, oral | Pheburane (oral) | Not reviewed | Non-preferred |
The second table includes the January PDL from the April PDL recommendations:
PDL Class | Drug | Current PDL Status | Recommended Status |
|---|---|---|---|
Anti-Allergens, Oral | Oralair (sublingual) | Non-preferred | Preferred |
Anti-Allergens, Oral | Palforzia titration capsule (oral) | Non-preferred | Preferred |
Anticoagulants | Pradaxa pellet pack (oral) | Not reviewed | Non-preferred |
Anticoagulants | Xarelto suspension (oral) | Non-preferred | Preferred |
Antidepressants, other | Venlafaxine Besylate ER (oral) | Not reviewed | Non-preferred |
Antidepressants, other | Viibryd (oral) | Non-preferred | Preferred |
Antivirals, oral | Valcyte tablet (oral) | Non-preferred | Preferred |
Antivirals, oral | Valganciclovir tablet (oral) | Preferred | Non-preferred |
Bronchodilators, beta agonist | Serevent (inhalation) | Non-preferred | Preferred |
Bronchodilators, beta agonist | Xopenex HFA (inhalation) | Non-preferred | Preferred |
Bronchodilators, beta agonist | Xopenex neb soln (inhalation) | Non-preferred | Preferred |
Cough and Cold, non-narcotic | Duraflu tablet OTC (oral) | Non-preferred | Preferred |
Cough and Cold, non-narcotic | Polytussin DM OTC (Oral) | Non-preferred | Preferred |
Cough and Cold, non-narcotic | Vanacof DMX Liquid OTC (oral) | Non-preferred | Preferred |
Cytokine and CAM Antagonists | Amjevita autoinjector HC (subcutaneous) | Not reviewed | Non-preferred |
Cytokine and CAM Antagonists | Amjevita autoinjector LC (subcutaneous) | Not reviewed | Non-preferred |
Cytokine and CAM Antagonists | Amjevita syringe (subcutaneous) | Not reviewed | Non-preferred |
Hemophilia Treatment | Hemgenix (intraven) | Not reviewed | Preferred |
Immunomodulators, Asthma | Tezspire pen (subcutaneous) | Not reviewed | Non-preferred |
Immunomodulators, Atopic Dermatitis | Protopic (topical) | Preferred | Non-preferred |
Immunomodulators, Atopic Dermatitis | Tacrolimus (AG) (topical) | Non-preferred | Preferred |
Immunomodulators, Atopic Dermatitis | Tacrolimus (topical) | Non-preferred | Preferred |
Lipotropics, other | Praluent pen (subcutaneous) | Non-preferred | Preferred |
Lipotropics, other | Repatha pushtronex (subcutaneous) | Non-preferred | Preferred |
Lipotropics, other | Repatha sureclick (subcutaneous) | Non-preferred | Preferred |
Lipotropics, other | Repatha syringe (subcutaneous) | Non-preferred | Preferred |
Lipotropics, other | Vascepa (oral) | Non-preferred | Preferred |
Pediatric Vitamin Preparations | Pedi Mvi No.17 with fluoride chew (oral) | Non-preferred | Preferred |
Pediatric Vitamin Preparations | PNV NO.15/IRON FUM & PS CMP/FA (Oral) | Non-preferred | Preferred |
Pediatric Vitamin Preparations | Prenatal Vit #76/Iron,Carb/FA (Oral) | Non-preferred | Preferred |
Pediatric Vitamin Preparations | Prenate Enhance (Oral) | Non-preferred | Preferred |
Thrombopoiesis Stimulating Proteins | Promacta suspension (oral) | Non-preferred | Non-preferred |
Urea Cycle Disorders, Oral | Carbaglu (oral) | Non-preferred | Preferred |
Urea Cycle Disorders, Oral | Pheburane (oral) | Non-preferred | Preferred |
Single Drug Reviews |
|
|
|
Antifungals, oral | Noxafil suspdr pkt (oral) | Not reviewed | Non-preferred |
Colony Stimulating Factors | Rolvedon syringe (subcutaneous) | Not reviewed | Non-preferred |
Colony Stimulating Factors | Stimufend syringe (subcutaneous) | Not reviewed | Non-preferred |
HIV/AIDS | Sunlenca tablet (oral) | Not reviewed | Preferred |
Hypoglycemics, insulin and related agents | Basaglar tempo pen (subcutane.) | Not reviewed | Non-preferred |
Hypoglycemics, insulin and related agents | Humalog tempo pen (subcutane.) | Not reviewed | Non-preferred |
Hypoglycemics, insulin and related agents | Lyumjev tempo pen (subcutane.) | Not reviewed | Non-preferred |